Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer’s Dementia: Evidence From the CitAD Study
American Journal of Psychiatry2016Vol. 173(5), pp. 473–480
Citations Over TimeTop 10% of 2016 papers
Anne K. Leonpacher, Matthew E. Peters, Lea T. Drye, Kelly M. Makino, Jeffery Newell, Davangere P. Devanand, Constantine Frangakis, Cynthia A. Munro, Jacobo Mintzer, Bruce G. Pollock, Paul B. Rosenberg, Lon S. Schneider, David Shade, Daniel Weintraub, Jerome A. Yesavage, Constantine G. Lyketsos, Anton P. Porsteinsson
Abstract
While dosage constraints must be considered because of citalopram's adverse effect profile, this agent's overall therapeutic effects in patients with Alzheimer's disease and agitation, in addition to efficacy for agitation/aggression, included reductions in the frequency of irritability, anxiety, and delusions; among patients who had these symptoms at week 9, they included a reduction in the severity of hallucinations but an increase in the severity of sleep/nighttime behavior disorders.
Related Papers
- → Irritability During the Month of Ramadan(2000)114 cited
- → Irritability Following Traumatic Brain Injury(1999)64 cited
- → Early Predictors of Adolescent Irritability(2021)14 cited
- → Relational dimension of irritability following traumatic brain injury: A qualitative analysis(2012)22 cited
- → Possible Bipolar Nature of Irritability in Major Depressive Disorder(2005)10 cited